Kastrissios H - Search Results

1

A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.

Chao NJ, Kastrissios H, Long GD, Negrin RS, Horning SJ, Wong RM, Blaschke TF, Blume KG. Chao NJ, et al. Among authors: kastrissios h. Cancer. 1995 Mar 15;75(6):1354-9. doi: 10.1002/1097-0142(19950315)75:6<1354::aid-cncr2820750618>3.0.co;2-m. Cancer. 1995. PMID: 7882286 Clinical Trial.

2

Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients.

Kastrissios H, Chao NJ, Blaschke TF. Kastrissios H, et al. Cancer Chemother Pharmacol. 1996;38(5):425-30. doi: 10.1007/s002800050506. Cancer Chemother Pharmacol. 1996. PMID: 8765435

3

Medication compliance as a feature in drug development.

Kastrissios H, Blaschke TF. Kastrissios H, et al. Annu Rev Pharmacol Toxicol. 1997;37:451-75. doi: 10.1146/annurev.pharmtox.37.1.451. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131261 Review.

4

Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.

Kastrissios H, Suárez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke TF. Kastrissios H, et al. AIDS. 1998 Dec 3;12(17):2295-303. doi: 10.1097/00002030-199817000-00011. AIDS. 1998. PMID: 9863872 Clinical Trial.

5

Introducing medical students to medication noncompliance.

Kastrissios H, Flowers NT, Blaschke TF. Kastrissios H, et al. Clin Pharmacol Ther. 1996 May;59(5):577-82. doi: 10.1016/S0009-9236(96)90186-1. Clin Pharmacol Ther. 1996. PMID: 8646829 Clinical Trial.

6

The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker.

Kastrissios H, Suárez JR, Hammer S, Katzenstein D, Blaschke TF. Kastrissios H, et al. AIDS. 1998 Dec 3;12(17):2305-11. doi: 10.1097/00002030-199817000-00012. AIDS. 1998. PMID: 9863873 Clinical Trial.

7

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy.

Vanhove GF, Kastrissios H, Gries JM, Verotta D, Park K, Collier AC, Squires K, Sheiner LB, Blaschke TF. Vanhove GF, et al. Among authors: kastrissios h. Antimicrob Agents Chemother. 1997 Nov;41(11):2428-32. doi: 10.1128/AAC.41.11.2428. Antimicrob Agents Chemother. 1997. PMID: 9371345 Free PMC article. Clinical Trial.

8

A Markov mixed effect regression model for drug compliance.

Girard P, Blaschke TF, Kastrissios H, Sheiner LB. Girard P, et al. Among authors: kastrissios h. Stat Med. 1998 Oct 30;17(20):2313-33. doi: 10.1002/(sici)1097-0258(19981030)17:20<2313::aid-sim935>3.0.co;2-v. Stat Med. 1998. PMID: 9819830

9

Do we need full compliance data for population pharmacokinetic analysis?

Girard P, Sheiner LB, Kastrissios H, Blaschke TF. Girard P, et al. Among authors: kastrissios h. J Pharmacokinet Biopharm. 1996 Jun;24(3):265-82. doi: 10.1007/BF02353671. J Pharmacokinet Biopharm. 1996. PMID: 8970015

10

Improved combined solid-phase extraction-RIA method for quantifying zalcitabine in plasma.

Kastrissios H, Nakano M, Burton P, Blaschke T. Kastrissios H, et al. Clin Chem. 1996 Mar;42(3):465-6. Clin Chem. 1996. PMID: 8598115 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters